Home / Feed item / OIRM: Promising preclinical studies for use of hESC derived cardiomyocytes #medbydesign
OIRM: Promising preclinical studies for use of hESC derived cardiomyocytes #medbydesign
Our Vision
OIRM will transform the treatment of incurable diseases, making Ontario a global leader in the development and dissemination and dissemination of stem cell-based products and therapies.
